Interview: Ruth Scott of Integra Community Care Networks
Recent developments in AI and machine learning have greatly improved the patient and clinician experience utilizing remote patient monitoring programs. New solutions solve for many
$300M Series D funding secured & Dr. Omar Ishrak appointed Biofourmis Chairman Learn More
Recent developments in AI and machine learning have greatly improved the patient and clinician experience utilizing remote patient monitoring programs. New solutions solve for many
Digital medicine technologies, such as prescription digital therapeutics (DTx) for use as a companion therapy with high-value drugs, can help pharmaceutical companies improve efficacy and
What’s next in Remote Patient Monitoring: 3 health systems discuss revolutionizing care at home For many healthcare systems, remote patient monitoring programs are still in
Healthcare has never been static — disruption and innovation are constants. Still, COVID-19 has ushered the industry into a uniquely transformative era. The challenges and
Panel: Patient centricity’s state of play – what has pharma actually achieved? Hear from patient advocacy experts on: Balancing science and technology with patient experience
The Hospital at Home Virtual Briefing convenes thought leaders like Dr. Bruce Leff, Dr. Stephanie Murphy, Dr. Irshad Siddiqui and others to discuss how the
Until recently, acute care technological innovations were centered on improvements in procedural interventions or critical care. Accelerated by the pandemic, there has been a
Virtual Care Across the Care Continuum: Acute, Post-Acute, and Chronic Care Becker’s Webinar and Description Ongoing innovations in reimbursement, care models, software, and biosensors
Digital Medicine has emerged an invaluable tool for the pharmaceutical industry. From developing differentiated digital therapeutics to complimenting existing drug therapies for improved patient adherence
This video features Biofourmis Chief Operating Officer Jaydev Thakkar’s presentation at DTx West 2022, covering Key Considerations for Pharma Developing a Digital Therapeutic. Biofourmis is